Literature DB >> 25483512

Tailored immunity by skin antigen-presenting cells.

Clement Levin1, Helene Perrin, Behazine Combadiere.   

Abstract

Skin vaccination aims at targeting epidermal and dermal antigen-presenting cells (APCs), indeed many subsets of different origin endowed with various functions populate the skin. The idea that the skin could represent a particularly potent site to induce adaptive and protective immune response emerged after the success of vaccinia virus vaccination by skin scarification. Recent advances have shown that multiple subsets of APCs coexist in the skin and participate in immunity to infectious diseases. Induction of an adaptive immune response depends on the initial recognition and capture of antigens by skin APCs and their transport to lymphoid organs. Innovative strategies of vaccination have thus been developed to target skin APCs for tailored immunity, hence this review will discuss recent insights into skin APC subsets characterization and how they can shape adaptive immune responses.

Entities:  

Keywords:  Langerhans cell; cutaneous route of immunization; dendritic cell subsets; immune response; skin; vaccination

Mesh:

Substances:

Year:  2014        PMID: 25483512      PMCID: PMC4514408          DOI: 10.4161/hv.34299

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  112 in total

1.  Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.

Authors:  Jason Waithman; Rhys S Allan; Hiroshi Kosaka; Hiroaki Azukizawa; Ken Shortman; Manfred B Lutz; William R Heath; Francis R Carbone; Gabrielle T Belz
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

2.  Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.

Authors:  Hideki Fujita; Kristine E Nograles; Toyoko Kikuchi; Juana Gonzalez; John A Carucci; James G Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-08       Impact factor: 11.205

3.  CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity.

Authors:  Yosuke Kumamoto; Melissa Linehan; Jason S Weinstein; Brian J Laidlaw; Joseph E Craft; Akiko Iwasaki
Journal:  Immunity       Date:  2013-09-26       Impact factor: 31.745

4.  Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues.

Authors:  Jenny Valladeau; Valérie Clair-Moninot; Colette Dezutter-Dambuyant; Jean-Jacques Pin; Adrien Kissenpfennig; Marie-Genevieve Mattéi; Smina Ait-Yahia; Elizabeth E M Bates; Bernard Malissen; Franz Koch; François Fossiez; Nikolaus Romani; Serge Lebecque; Sem Saeland
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

5.  Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Authors:  Eynav Klechevsky; Rimpei Morita; Maochang Liu; Yanying Cao; Sebastien Coquery; Luann Thompson-Snipes; Francine Briere; Damien Chaussabel; Gerard Zurawski; A Karolina Palucka; Yoram Reiter; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

6.  Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

Authors:  Samar Hamdy; Ommoleila Molavi; Zengshuan Ma; Azita Haddadi; Aws Alshamsan; Zahra Gobti; Sara Elhasi; John Samuel; Afsaneh Lavasanifar
Journal:  Vaccine       Date:  2008-08-03       Impact factor: 3.641

7.  Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion.

Authors:  Saïdi M'Homa Soudja; Anne L Ruiz; Julien C Marie; Grégoire Lauvau
Journal:  Immunity       Date:  2012-08-30       Impact factor: 31.745

8.  Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.

Authors:  Julien Seneschal; Xiaodong Jiang; Thomas S Kupper
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

Review 9.  Human dendritic cell functional specialization in steady-state and inflammation.

Authors:  Arjan Boltjes; Femke van Wijk
Journal:  Front Immunol       Date:  2014-04-01       Impact factor: 7.561

10.  Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Authors:  Ronald H Behrens; Jakob P Cramer; Tomas Jelinek; Hilary Shaw; Frank von Sonnenburg; Darren Wilbraham; Thomas Weinke; David J Bell; Edwin Asturias; Hermann L Enkerlin Pauwells; Roberto Maxwell; Mercedes Paredes-Paredes; Gregory M Glenn; Shailesh Dewasthaly; Donald M Stablein; Zhi-Dong Jiang; Herbert L DuPont
Journal:  Lancet Infect Dis       Date:  2013-11-29       Impact factor: 25.071

View more
  20 in total

Review 1.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Authors:  Christopher J Nirschl; Niroshana Anandasabapathy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.

Authors:  Benedikt Asbach; Karen V Kibler; Josef Köstler; Beatriz Perdiguero; Nicole L Yates; Sherry Stanfield-Oakley; Georgia D Tomaras; Shing-Fen Kao; Kathryn E Foulds; Mario Roederer; Michael S Seaman; David C Montefiori; Robert Parks; Guido Ferrari; Donald N Forthal; Sanjay Phogat; James Tartaglia; Susan W Barnett; Steven G Self; Raphael Gottardo; Anthony D Cristillo; Deborah E Weiss; Lindsey Galmin; Song Ding; Jonathan L Heeney; Mariano Esteban; Bertram L Jacobs; Giuseppe Pantaleo; Ralf Wagner
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity.

Authors:  Laura A Novotny; Lauren O Bakaletz
Journal:  Vaccine       Date:  2020-01-27       Impact factor: 3.641

4.  Intradermal Synthetic DNA Vaccination Generates Leishmania-Specific T Cells in the Skin and Protection against Leishmania major.

Authors:  Lumena Louis; Megan Clark; Megan C Wise; Nelson Glennie; Andrea Wong; Kate Broderick; Jude Uzonna; David B Weiner; Phillip Scott
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.

Authors:  Jonathan M Williams; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

Review 6.  Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Expert Opin Drug Deliv       Date:  2020-10-06       Impact factor: 8.129

7.  Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial.

Authors:  G Haidari; A Cope; A Miller; S Venables; C Yan; H Ridgers; K Reijonen; D Hannaman; A Spentzou; P Hayes; G Bouliotis; A Vogt; S Joseph; B Combadiere; S McCormack; R J Shattock
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

8.  Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid.

Authors:  Anne Marit de Groot; Anouk C M Platteel; Nico Kuijt; Peter J S van Kooten; Pieter Jan Vos; Alice J A M Sijts; Koen van der Maaden
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

Review 9.  Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity.

Authors:  Matthias P Domogalla; Patricia V Rostan; Verena K Raker; Kerstin Steinbrink
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

10.  DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.

Authors:  Stefan Petkov; Elizaveta Starodubova; Anastasia Latanova; Athina Kilpeläinen; Oleg Latyshev; Simons Svirskis; Britta Wahren; Francesca Chiodi; Ilya Gordeychuk; Maria Isaguliants
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.